Atlas Trials

Safety Study of Homeo-GH (Bone Marrow Derived Clonal Mesenchymal Stem Cell) to Treat Acute/Chronic Graft Versus Host Disease (GVHD)

Clinical trial NCT01318330 · COMPLETED

Trial details

NCT number
NCT01318330
Sponsor
HomeoTherapy Co., Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Graft-vs-Host Disease
Start date
2010-11-01
Primary completion
2011-12-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.